DK0869184T3 - Vaccine til immunisering mod TBE-virusinfektioner samt en fremgangsmåde til fremstilling deraf - Google Patents
Vaccine til immunisering mod TBE-virusinfektioner samt en fremgangsmåde til fremstilling derafInfo
- Publication number
- DK0869184T3 DK0869184T3 DK98107383T DK98107383T DK0869184T3 DK 0869184 T3 DK0869184 T3 DK 0869184T3 DK 98107383 T DK98107383 T DK 98107383T DK 98107383 T DK98107383 T DK 98107383T DK 0869184 T3 DK0869184 T3 DK 0869184T3
- Authority
- DK
- Denmark
- Prior art keywords
- vaccine
- preparation
- well
- virus infections
- immunization against
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 230000003053 immunization Effects 0.000 title 1
- 238000002649 immunization Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 230000009385 viral infection Effects 0.000 title 1
- 241000710831 Flavivirus Species 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 108091026890 Coding region Proteins 0.000 abstract 1
- 206010054261 Flavivirus infection Diseases 0.000 abstract 1
- 101710085938 Matrix protein Proteins 0.000 abstract 1
- 101710127721 Membrane protein Proteins 0.000 abstract 1
- 101800001127 Protein prM Proteins 0.000 abstract 1
- 239000013600 plasmid vector Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24161—Methods of inactivation or attenuation
- C12N2770/24162—Methods of inactivation or attenuation by genetic engineering
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0135294A AT402897B (de) | 1994-07-08 | 1994-07-08 | Verbesserte vakzine zur immunisierung gegen tbe-virusinfektionen sowie ein verfahren zu dessen herstellung |
| AT0087195A AT405607B (de) | 1995-05-23 | 1995-05-23 | Verbesserte vakzine zur immunisierung gegen tbe-virusinfektionen sowie ein verfahren zu dessen herstellung |
| EP95890132A EP0691404B1 (de) | 1994-07-08 | 1995-07-06 | Vakzine zur Immunisierung gegen TBE-Virusinfektionen sowie ein Verfahren zu dessen Herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0869184T3 true DK0869184T3 (da) | 2001-12-17 |
Family
ID=25594155
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95890132T DK0691404T3 (da) | 1994-07-08 | 1995-07-06 | Vaccine til immunisering mod TBE-virusinfektioner samt en fremgangsmåde til fremstilling deraf |
| DK98107383T DK0869184T3 (da) | 1994-07-08 | 1995-07-06 | Vaccine til immunisering mod TBE-virusinfektioner samt en fremgangsmåde til fremstilling deraf |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95890132T DK0691404T3 (da) | 1994-07-08 | 1995-07-06 | Vaccine til immunisering mod TBE-virusinfektioner samt en fremgangsmåde til fremstilling deraf |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP0691404B1 (da) |
| AT (2) | ATE206459T1 (da) |
| CZ (1) | CZ282927B6 (da) |
| DE (2) | DE59509667D1 (da) |
| DK (2) | DK0691404T3 (da) |
| ES (2) | ES2165109T3 (da) |
| FI (2) | FI117974B (da) |
| HU (2) | HU219503B (da) |
| RU (1) | RU2150294C1 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69833388D1 (de) | 1997-11-20 | 2006-04-13 | Us Army Medical Res Materiel C | Dna impfstoffe gegen zecken-flavivieren |
| US7425437B2 (en) | 1999-11-26 | 2008-09-16 | Crucell Holland B.V. | Vaccines against West Nile Virus |
| CA2481479C (en) * | 2002-02-26 | 2012-12-11 | Maxygen, Inc. | Novel flavivirus antigens |
| CA2591665C (en) | 2004-12-20 | 2015-05-05 | Crucell Holland B.V. | Binding molecules capable of neutralizing west nile virus and uses thereof |
| CA2608058C (en) | 2005-05-12 | 2013-09-10 | Crucell Holland B.V. | Host cell specific binding molecules capable of neutralizing viruses and uses thereof |
| EP3018142A1 (en) | 2006-06-06 | 2016-05-11 | Crucell Holland B.V. | Human binding molecules having killing activity against staphylococci and uses thereof |
| JP2011514881A (ja) | 2007-11-09 | 2011-05-12 | ザ ソルク インスティテュート フォー バイオロジカル スタディーズ | 免疫増強剤としてのｔａｍ受容体阻害剤の使用および免疫抑制剤としてのｔａｍ活性化剤の使用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE122055T1 (de) * | 1987-03-20 | 1995-05-15 | Immuno Ag | Dna- und rna-moleküle des westlichen subtyps des fsme-virus, polypeptide, die von diesen molekülen codiert werden, und deren verwendung. |
| MY109299A (en) * | 1990-08-15 | 1996-12-31 | Virogenetics Corp | Recombinant pox virus encoding flaviviral structural proteins |
| WO1992003161A1 (en) | 1990-08-27 | 1992-03-05 | The United States Of America, Represented By The Secretary, United States Department Of Commerce | Flavivirus envelope proteins with increased immunogenicity for use in immunization against virus infection |
| ES2242954T3 (es) | 1992-03-11 | 2005-11-16 | Powderject Vaccines, Inc. | Vacuna genetica para el virus de la inmunodeficiencia. |
-
1995
- 1995-06-21 HU HU9501832A patent/HU219503B/hu not_active IP Right Cessation
- 1995-06-21 HU HU9903233A patent/HU224199B1/hu not_active IP Right Cessation
- 1995-07-06 ES ES98107383T patent/ES2165109T3/es not_active Expired - Lifetime
- 1995-07-06 AT AT98107383T patent/ATE206459T1/de active
- 1995-07-06 DE DE59509667T patent/DE59509667D1/de not_active Expired - Lifetime
- 1995-07-06 EP EP95890132A patent/EP0691404B1/de not_active Expired - Lifetime
- 1995-07-06 DK DK95890132T patent/DK0691404T3/da active
- 1995-07-06 AT AT95890132T patent/ATE198909T1/de active
- 1995-07-06 EP EP98107383A patent/EP0869184B1/de not_active Expired - Lifetime
- 1995-07-06 DE DE59508988T patent/DE59508988D1/de not_active Expired - Lifetime
- 1995-07-06 ES ES95890132T patent/ES2155510T3/es not_active Expired - Lifetime
- 1995-07-06 DK DK98107383T patent/DK0869184T3/da active
- 1995-07-07 RU RU95113194/14A patent/RU2150294C1/ru not_active IP Right Cessation
- 1995-07-07 CZ CZ951769A patent/CZ282927B6/cs not_active IP Right Cessation
- 1995-07-07 FI FI953371A patent/FI117974B/fi not_active IP Right Cessation
-
2007
- 2007-01-17 FI FI20070041A patent/FI118222B/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FI953371A0 (fi) | 1995-07-07 |
| ES2155510T3 (es) | 2001-05-16 |
| EP0691404A2 (de) | 1996-01-10 |
| FI118222B (fi) | 2007-08-31 |
| HU219503B (hu) | 2001-04-28 |
| FI20070041A (fi) | 2007-01-17 |
| EP0691404B1 (de) | 2001-01-24 |
| HU224199B1 (hu) | 2005-06-28 |
| ES2165109T3 (es) | 2002-03-01 |
| ATE198909T1 (de) | 2001-02-15 |
| DK0691404T3 (da) | 2001-03-19 |
| DE59509667D1 (de) | 2001-11-08 |
| HUT72395A (en) | 1996-04-29 |
| FI117974B (fi) | 2007-05-15 |
| DE59508988D1 (de) | 2001-03-01 |
| EP0869184B1 (de) | 2001-10-04 |
| EP0869184A2 (de) | 1998-10-07 |
| RU2150294C1 (ru) | 2000-06-10 |
| HU9903233D0 (en) | 1999-11-29 |
| CZ176995A3 (en) | 1996-01-17 |
| FI953371A (fi) | 1996-01-09 |
| ATE206459T1 (de) | 2001-10-15 |
| CZ282927B6 (cs) | 1997-11-12 |
| EP0869184A3 (de) | 1999-05-12 |
| EP0691404A3 (de) | 1997-11-12 |
| HU9501832D0 (en) | 1995-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69829668D1 (de) | Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe | |
| CY1106350T1 (el) | Εμβολιο φυματιωσης | |
| DE58906121D1 (de) | Rekombinantes Vaccinia-Virus MVA. | |
| DK0561890T3 (da) | DNA ekspressionssystemer baseret på alphavira | |
| EP1847549A3 (en) | Papillomavirus polyprotein constructs | |
| FI20070041A (fi) | Parannettu rokote Flavivirusinfektioiden vastaiseen immuunisointiin | |
| CY1105600T1 (el) | Κατασκευασματα νουκλεϊκων οξεων για γενετικη ανοσοποιηση | |
| BR9605153B1 (pt) | vacina de combinação, e, kit de vacinação. | |
| NO944245D0 (no) | Rekombinante DNA-molekyler som koder for aminopeptidase-enzymer og deres anvendelse ved fremstilling av vaksiner mot helmintinfeksjoner | |
| DK606285D0 (da) | Vaccine mod rabies samt fremgangsmaade til fremstilling deraf | |
| WO2002062296A3 (en) | Methods and compositions useful for stimulating an immune response | |
| NZ500540A (en) | Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae | |
| ATE346931T1 (de) | Clostridium perfringens impfstoff | |
| DK457687A (da) | Antigenisk aktive proteiner og peptider, og vacciner mod virus for felin peritonitis (fipv) med indhold af saadanne proteiner eller peptider | |
| EP0236977A3 (en) | Bovine virus diarrhea and hog cholera vaccines | |
| DK0778894T3 (da) | Vaccine mod infektiös felin peritonitis | |
| PT729509E (pt) | Vacina contra papeira contendo uma estirpe do virus jerryl-lynn | |
| IL91609A0 (en) | Allelic variants of plasmodium falciparum merozoite surface antigen | |
| DK381787A (da) | Rensede antigener med vaccineegenskaber mod b. pertussis, midler, navnlig rekombinant-dna, til fremstilling deraf og vaccinepraeparater indeholdende disse | |
| MY106940A (en) | Allelic variants of plasmodium falciparum merozoite surface antigen. | |
| AR010517A1 (es) | Compuestos y metodos para la inmunoterapia y diagnostico de tuberculosis | |
| GB2244273A (en) | Allelic variants of plasmodium falciparum merozoite surface antigen. |